A Diabetic with Creatinine 3.1 and Three Requests
A 58-year-old man from Nagpur, a bus mechanic with type 2 diabetes for 14 years, attends a screening camp. For eight months he has taken diclofenac 75 mg twice daily for knee pain and has followed a 'bodybuilding' diet with a protein powder, giving a total protein intake of about 1.8 g per kg per day. He feels tired and slightly breathless on stairs but has no chest pain. Results: serum creatinine 3.1 mg/dL (it was 1.2 two years ago), urea 96 mg/dL, eGFR 26 mL/min/1.73 m², potassium 5.7 mmol/L, bicarbonate 17 mmol/L, haemoglobin 9.4 g/dL, urine albumin-to-creatinine ratio 620 mg/g, blood pressure 158/96 mmHg, urine output 1.4 L per day. He has read that 'kidney patients must avoid protein' and that 'salt substitutes are heart-healthy', and he asks whether he needs dialysis this month.
1. Explain how one process, loss of functioning nephrons, accounts for the potassium of 5.7, the bicarbonate of 17 and the haemoglobin of 9.4.
Read the worked answer
An eGFR of 26 mL/min/1.73 m² means roughly a quarter of normal filtration, with surviving nephrons hyperfiltering. Each abnormality follows from that single loss.
Potassium
Filtered potassium is mostly reabsorbed in the proximal tubule; plasma potassium is set mainly by distal secretion, which needs aldosterone, sodium delivery to the distal nephron and adequate tubular flow. With few distal tubules, reduced sodium delivery and low flow, secretory capacity falls. Diclofenac adds a second hit: cyclo-oxygenase inhibition reduces prostaglandin-driven renin release, so angiotensin II and aldosterone fall, and potassium retention worsens. Acidosis shifts potassium out of cells, and the insulin deficiency of type 2 diabetes reduces cellular potassium uptake.
Bicarbonate
The failing kidney cannot generate enough ammonium to excrete the daily acid load, so hydrogen ion retention consumes bicarbonate and the value settles at 17 mmol/L. This is a hyperchloraemic metabolic acidosis of chronic kidney disease, and it further raises plasma potassium.
Haemoglobin
The peritubular interstitial fibroblasts that make erythropoietin are lost as nephrons are replaced by fibrosis, so red cell production falls; uraemic toxins shorten red cell survival, and long-term diclofenac use risks gastrointestinal blood loss. The result is a normocytic normochromic anaemia.
The albumin-to-creatinine ratio of 620 mg/g and the blood pressure identify diabetic nephropathy as the cause of the nephron loss.
2. Judge the three requests: the potassium-based salt substitute, the protein powder, and dialysis this month.
Read the worked answer
Salt substitute: no
Potassium-based salt substitutes are contraindicated at a plasma potassium of 5.7 mmol/L. Raising potassium further risks cardiac arrhythmia and sudden death. An ECG should be checked now, sodium intake reduced to under 5 g of salt per day, and potassium-lowering measures discussed with a physician. Any salt substitute he has at home should be taken away.
Protein powder: no; and 'avoid protein' is also wrong
At 1.8 g per kg per day he is well above the 0.6–0.8 g per kg per day usually advised in advanced chronic kidney disease. High protein increases glomerular hyperfiltration, urea generation and acid load, and the powder adds potassium and phosphate. But he should not go to a very low intake either; the aim is a controlled intake of mostly high-biological-value protein with adequate calories, supervised by a dietitian.
Diclofenac: stop
NSAIDs constrict the afferent arteriole, blunt prostaglandin-mediated renin release and can cause interstitial nephritis. In a patient with eGFR 26 and potassium 5.7 they are doing real harm. Alternative analgesia must be arranged.
Dialysis: not this month
Dialysis is usually started when eGFR falls below about 10, or earlier for refractory hyperkalaemia, acidosis, fluid overload or uraemic symptoms. With eGFR 26, urine output 1.4 litres per day and no such features, he does not need it yet. He does need blood pressure control, glycaemic control, repeat potassium and bicarbonate within two weeks, and planned long-term follow-up.
3. What single piece of information would tell you how much of this is acute-on-chronic rather than stable chronic kidney disease, and how would it change management?
Read the worked answer
The decisive test is a repeat creatinine after removing the insults.
The history already shows chronic disease: creatinine 1.2 two years ago, heavy albuminuria and longstanding diabetes. What is not yet known is whether part of the current 3.1 mg/dL is reversible. Withhold diclofenac, ensure he is not volume-depleted, treat the blood pressure, and repeat creatinine, potassium and bicarbonate in about two weeks. A renal ultrasound is also useful: small, echogenic kidneys with a thin cortex indicate long-standing scarring, whereas normal-sized kidneys leave more room for recovery.
Interpretation
- A fall of 0.5 mg/dL or more means a substantial acute component, most likely from NSAID-induced afferent vasoconstriction, and the true chronic baseline is better than it appears.
- No change confirms stable but advanced chronic disease, and the priority shifts to slowing progression rather than reversing it.
How management changes
If the creatinine falls, the conversation becomes optimistic and the plan is strict avoidance of nephrotoxins plus continued monitoring. If it does not, dietary counselling, potassium management, anaemia investigation and preparation for future renal replacement therapy become immediate rather than theoretical. Either way, one cheap repeat blood test changes the whole message given to the patient.